ES485154A1 - Process for producing oxymorphone - Google Patents

Process for producing oxymorphone

Info

Publication number
ES485154A1
ES485154A1 ES485154A ES485154A ES485154A1 ES 485154 A1 ES485154 A1 ES 485154A1 ES 485154 A ES485154 A ES 485154A ES 485154 A ES485154 A ES 485154A ES 485154 A1 ES485154 A1 ES 485154A1
Authority
ES
Spain
Prior art keywords
oxymorphone
producing
producing oxymorphone
utilizing
lewis base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485154A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of ES485154A1 publication Critical patent/ES485154A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polarising Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for producing oxymorphone by converting oxycodone utilizing a suitable boron reagent in the presence of a weak Lewis base attenuating agent.
ES485154A 1978-10-19 1979-10-18 Process for producing oxymorphone Expired ES485154A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19

Publications (1)

Publication Number Publication Date
ES485154A1 true ES485154A1 (en) 1980-06-16

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
ES485154A Expired ES485154A1 (en) 1978-10-19 1979-10-18 Process for producing oxymorphone

Country Status (16)

Country Link
JP (1) JPS55501025A (en)
AU (1) AU5189779A (en)
BE (1) BE879494A (en)
CA (1) CA1108132A (en)
CS (1) CS211364B2 (en)
DK (1) DK258280A (en)
ES (1) ES485154A1 (en)
FI (1) FI793235A (en)
FR (1) FR2439201A1 (en)
GB (1) GB2049680A (en)
IL (1) IL58489A0 (en)
IT (1) IT7969032A0 (en)
NL (1) NL7920126A (en)
NO (1) NO793297L (en)
SE (1) SE8004454L (en)
WO (1) WO1980000841A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (en) * 1988-09-13 1990-11-30 Sanofi Sa PROCESS FOR THE PREPARATION OF MORPHINANE DERIVATIVES
WO1991005768A1 (en) * 1989-10-16 1991-05-02 The United States Of America, Represented By The Secretary, United States Department Of Commerce Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
CN1268338C (en) 2001-07-06 2006-08-09 恩德制药公司 Oral administration of 6-hydroxy-oxymorphone for use as antalgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Anti-abuse dosage form
DE10361596A1 (en) 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
DE102004032049A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH Anti-abuse, oral dosage form
DE102005005449A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Process for producing an anti-abuse dosage form
MX2008010921A (en) 2006-03-02 2008-09-03 Mallinckrodt Inc Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds.
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
BR112012001244A2 (en) 2009-07-22 2020-12-08 Gruünenthal Gmbh Tamper Resistant DOSAGE FORM, ITS PRODUCTION PROCESS, AND PACKAGING CONTAINING SUCH FORM
RU2604676C2 (en) 2010-09-02 2016-12-10 Грюненталь Гмбх Destruction-resistant dosage form containing an inorganic salt
AR082862A1 (en) 2010-09-02 2013-01-16 Gruenenthal Gmbh ALTERATION RESISTANT DOSAGE FORM INCLUDING AN ANIONIC POLYMER
BR112014002022A2 (en) 2011-07-29 2017-02-21 Gruenenthal Gmbh tamper-resistant tablet providing immediate drug release
PT2736497T (en) 2011-07-29 2017-11-30 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
ES2692944T3 (en) 2012-04-18 2018-12-05 Grünenthal GmbH Pharmaceutical dosage form resistant to handling and resistant to rapid discharge of the dose
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX2015016254A (en) 2013-05-29 2016-04-20 Gruenenthal Gmbh Tamper resistant dosage form with bimodal release profile.
MX371432B (en) 2013-05-29 2020-01-30 Gruenenthal Gmbh Tamper-resistant dosage form containing one or more particles.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105934241B (en) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 Preparation of powdered pharmaceutical composition by cryogenic grinding
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
CN107889459A (en) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 Tamper resistant dosage form with release immediately and to solvent-extracted resistance
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
EP3252055B1 (en) 2016-05-31 2018-09-19 Alcaliber Investigacion Desarrollo e Innovacion SLU Process for obtaining 3,14-diacetyloxymorphone from oripavine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
NL7920126A (en) 1980-08-29
SE8004454L (en) 1980-06-16
DK258280A (en) 1980-06-17
FI793235A (en) 1980-04-20
NO793297L (en) 1980-04-22
GB2049680A (en) 1980-12-31
BE879494A (en) 1980-02-15
IL58489A0 (en) 1980-01-31
WO1980000841A1 (en) 1980-05-01
AU5189779A (en) 1980-04-24
FR2439201A1 (en) 1980-05-16
CS211364B2 (en) 1982-02-26
IT7969032A0 (en) 1979-10-18
CA1108132A (en) 1981-09-01
JPS55501025A (en) 1980-11-27

Similar Documents

Publication Publication Date Title
ES485154A1 (en) Process for producing oxymorphone
PT69523A (en) Process for producing an activated oxid complex catalyst
YU83079A (en) Process for producing iminoquinazoline
YU244277A (en) Process for obtaining spirohydantoin compunds
GB2006230A (en) Process for producing soft resins
PT70244A (en) Process for producing an aldehyde-treated allergen
MY8100293A (en) Asbestos-cement laminates
GB2055845B (en) Process for producing phenolic foams
YU177181A (en) Process for producing 7-substituted benzopyrines
JPS5272301A (en) Conduit for directive boring in ocean
JPS53111018A (en) Process for preparing 22arylpropionate by direct coupling utilyzing mixed halogenized magnesium complex
DE2960472D1 (en) Process for producing clad plate
YU146379A (en) Process for obtaining methanol
JPS5344363A (en) Process for producing sludge compost
JPS53119805A (en) Process for preparing epoxide
YU206777A (en) Process for obtaining 7-substituted aminoacetamido-oxadethia-cephalosporin
GB2037295B (en) Process for producing plasminogen activator
GB2018823B (en) Process for producing electromagnetic silicon steel
IL48588A (en) Process for lysing mycelial waste
ZA776877B (en) Process for making methanol
HU178014B (en) Process for producing 5-cyano-4-methyl-oxazole
PT66808B (en) Process for preparing 5-m-tolyloxyuracil useful as an anti-ulcer agent
DE2861314D1 (en) Process for producing modified phenolic resins
DE2860790D1 (en) A polycyclic ether antibiotic, process for producing it and its use for improving feed utilisation in animals
GB2015522B (en) Process for making ether sulphonates